Oorsprong van het eerstegraads netwerk van Olga Bioprocess Golub
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Bioprocess Capital Partners Ltd.
 Bioprocess Capital Partners Ltd. Investment ManagersFinance Bioprocess Capital Partners Ltd (BCP) is a venture capital firm founded in 2006. The firm is headquartered in Moscow, Russia.
2
| Private Company | Investment Managers | 2 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Olga Bioprocess Golub via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| Moscow State University Lomonosov | College/University | Doctorate Degree | |
| PHARMSYNTHEZ | Pharmaceuticals: Major | Director/Board Member | |
Avelas Biosciences, Inc.
 Avelas Biosciences, Inc. Medical/Nursing ServicesHealth Services Avelas Biosciences, Inc. develops integrated suite of therapeutic and imaging agents for treatment of cancer. It develops AVB-620, an intravenously administered in vivo fluorescent protease activatable peptide that detects, marks, and diagnoses cancer. The company was founded by Yon Chien Tsien, Quyen T. Nguyen and Michael A. Whitney in 2008 and is headquartered in La Jolla, CA. | Medical/Nursing Services | Director/Board Member | |
Incuron LLC
 Incuron LLC Pharmaceuticals: MajorHealth Technology Incuron LLC develops anticancer drugs. It provides an innovative pipeline of drugs to treat oncology and autoimmune disease for the global markets. The firm is a joint venture between Bioprocess Capital Ventures and Cleveland BioLabs. The company was founded in January 2010 and is headquartered in Moscow, Russia. | Pharmaceuticals: Major | Director/Board Member | |
| Ulyanovsk State University | College/University | Undergraduate Degree | |
Pharmstandard Ventures
 Pharmstandard Ventures Investment ManagersFinance Pharmstandard Ventures (Pharmstd Ventures) is a venture capital subsidiary of Pharmstandard PJSC headquartered in Moscow, Russia. The firm was founded in 2013 by Dr. Andrey Petrov. | Investment Managers | Chief Executive Officer | |
| XENETIC BIOSCIENCES, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Cantreva LLC | Chief Operating Officer | ||
| Togas Middle East LLC | Corporate Officer/Principal | ||
| Togas Group LLC | Corporate Officer/Principal |
Statistieken
Internationaal
| Rusland | 7 |
| Verenigde Staten | 5 |
| Verenigde Arabische Emiraten | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
| Health Services | 2 |
| Finance | 2 |
Operationeel
| Director/Board Member | 7 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 3 |
| Private Equity Investor | 1 |
| Chief Executive Officer | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Alexey Vinogradov | 10 |
| Elena Kasimova | 4 |
- Beurs
- Insiders
- Olga Bioprocess Golub
- Bedrijfsconnecties
